Cardioprotection by Recombinant Human Erythropoietin Following Acute Experimental Myocardial Infarction: Dose Response and Therapeutic Window Chanil MoonMelissa KrawczykMark I. Talan Basic Pharmacology 20 September 2005 Pages: 243 - 250
AT 1 Receptor Blockade Prevents Cardiac Dysfunction after Myocardial Infarction in Rats Corinne BerthonnecheThierry SulpiceFrançois Boucher Basic pharmacology 20 September 2005 Pages: 251 - 259
Aspirin Inhibits the Acute Arterial and Venous Vasodilator Response to Captopril in Patients with Chronic Heart Failure Iain M. MacIntryePardeep S. JhundJohn J. V. McMurray Clinical Pharmacology and Drug Studies 20 September 2005 Pages: 261 - 265
Propionyl-L-Carnitine Improves Hemodynamics and Metabolic Markers of Cardiac Perfusion during Coronary Surgery in Diabetic Patients Romuald LangoRyszard T. SmoleńskiMagdi H. Yacoub Clinical Pharmacology and Drug Studies 20 September 2005 Pages: 267 - 275
Effect of Nebivolol and Atenolol on Brachial Artery Flow-Mediated Vasodilation in Patients with Coronary Artery Disease John P. LekakisAthanassios ProtogerouMyron Mavrikakis Clinical Pharmacology and Drug Studies 20 September 2005 Pages: 277 - 281
Cardiac Ischemic Score Determines the Presence of Coronary Collateral Circulation Jeroen KoerselmanPeter P. Th. de Jaegerefor the SMART Study Group Clinical Pharmacology and Drug studies 20 September 2005 Pages: 283 - 289
Pharmacotherapy of Acute Coronary Syndromes: Medical Economics with an Emphasis on Clopidogrel Matthias BramkampKonstantin J. DedesThomas D. Szucs Pharmaco-Economics 20 September 2005 Pages: 291 - 299
Combination Therapy with Metolazone and Loop Diuretics in Outpatients with Refractory Heart Failure: An Observational Study and Review of the Literature Jens RosenbergFinn GustafssonPer Rossen Hildebrandt Review 20 September 2005 Pages: 301 - 306
